Pregnancy and Subsequent Glucose Intolerance in Women of Childbearing Age – Heeding the Early Warning Signs for Primary Prevention of Cardiovascular Disease in Women
Gunderson EP, Jaffe MG
JAMA Intern Med. Pub. online October 16, 2017
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Association of History of Gestational Diabetes with Long-term Cardiovascular Disease Risk in a Large Prospective Cohort of US Women
Tobias DK, Stuart JJ, Li S, et al.
JAMA Intern Med. Pub. online October 16, 2017
Leggi
How Low to Go with Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
Hong KN, Fuster V, Rosenson RS, et al.
J Am Coll Cardiol 2017;70(17):2171-85
Leggi
Comparison of In-Hospital Outcomes After Percutaneous Revascularization for Peripheral Arterial Disease in Patients with a Body Mass Index of >30 kg/m2 Versus ≤30 kg/m2 (from the National Inpatient Sample)
Doshi R, Rao G, Shlofmitz E, et al.
Am J Card 2017;120(9):1648-52
Leggi
Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST–Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation
Moscarella E, Spitaleri G, Brugaletta S
Am J Card 2017;120 (9):1460-6
Leggi
Effect of Body Mass Index on Clinical Events After Acute Coronary Syndromes
Lamelas, Schwalm J-D, Quazi I, et al.
Am J Card 2017;120 (9):1453-9
Leggi
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
Wolsk E, Claggett B, Diaz R, et al.
Circulation 2017;136:1560-2
Leggi
Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus with That of Heart Failure
Packer M
Circulation 2017;136:1548-59
Leggi
The Ethics of Conducting Clinical Trials with Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients with Comorbid Diabetes Mellitus and Heart Failure?
Butler J, Anker SD
Circulation 2017;136:1459-61
Leggi
Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia
Yu O, Azoulay L, Yin H, et al.
Am J Med. Pub. online 13 October 2017
Leggi